new
   Indications of Loteprednol Etabonate Suspension Eye Drops (Lotemax)
504
Sep 17, 2025

Loteprednol Etabonate Suspension Eye Drops (Lotemax) is a glucocorticoid ophthalmic preparation, mainly used for the treatment of ocular inflammatory diseases.

Indications of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Core Applicable Diseases

Loteprednol Etabonate Suspension Eye Drops is suitable for the short-term treatment of the following ocular inflammatory diseases:

Postoperative inflammation: Inflammatory reactions caused by surgeries such as cataract surgery.

Allergic conjunctivitis: Relieves symptoms such as hyperemia and pruritus of the eyelids and conjunctiva caused by exposure to allergens.

Non-infectious keratitis: Including non-infectious corneal lesions such as superficial punctate keratitis.

Action Characteristics

As a topical glucocorticoid, its anti-inflammatory effect is stronger than that of hydrocortisone, while it has less systemic absorption and higher efficacy.

Specifications and Properties of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Dosage Form and Concentration

Dosage form: White suspension eye drops, which need to be shaken well before use.

Specification: Commonly available as 5ml per bottle, containing 0.5% loteprednol etabonate (5mg/ml).

Composition

Active ingredient: Loteprednol Etabonate.

Excipients: Including glycerin, polysorbate 80, boric acid, etc. The pH value is approximately 7.0-8.0.

Physical properties: The suspension may separate into layers when left standing, and will return to a uniform state after being shaken well.

Usage

Instillation frequency: Usually 3-4 times a day, 1-2 drops each time; follow the doctor's advice for specific usage.

Precautions: Avoid the tip of the dropper touching the eyes or skin to prevent contamination of the liquid medicine.

Storage Method of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Environmental Requirements

Temperature: It is recommended to store at 15°C to 25°C (59°F to 77°F), and freezing should be avoided.

Light and moisture protection: Store in the original packaging to prevent direct light exposure and humid environments.

Expiration Date and Packaging

Expiration date after opening: Usually 4 weeks; any unused medicine beyond this period should be discarded.

Packaging integrity: Check the tightness of the bottle cap. If leakage or abnormalities of the suspension (such as discoloration, sedimentation) are found, the product should be discontinued.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Canakinumab (Ilaris): Dosage and Administration, Precautions, and Healthy Lifestyle

Canakinumab is an IL-1β inhibitor used for the treatment of various autoinflammatory diseases.

I. Dosage and...

Friday, April 17th, 2026, 10:36
Canakinumab (Ilaris): Side Effects, Management Strategies and Storage Instructions

Canakinumab is an IL-1β inhibitor indicated for various autoinflammatory diseases.

I. Common Side Effects of...

Friday, April 17th, 2026, 10:32
Selpercatinib (Retevmo): Dosage, Precautions, and Healthy Living

Selpercatinib (Retevmo) is an oral, precision-targeted antineoplastic agent that selectively inhibits the RET driver...

Thursday, April 16th, 2026, 11:47
Selpercatinib (Retevmo): Side Effects, Management Strategies, and Storage Guidelines

Selpercatinib (Retevmo) demonstrates significant efficacy in the treatment of various RET-driven tumors, yet it may...

Thursday, April 16th, 2026, 11:32
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved